The World Health Organisation’s (WHO) 2024 Global Hepatitis Report reveals that India is second only to China in the number of Hepatitis B and C infections, with 3.5 crore cases. Hepatitis, characterized by liver inflammation, poses significant health risks and can be fatal. The report highlights that 254 million people are affected by Hepatitis B and 50 million by Hepatitis C globally.
Hepatitis comprises five main strains: A, B, C, D, and E, each differing in transmission methods, severity, and geographical prevalence. Despite these differences, all strains can lead to liver disease.
The report emphasizes that individuals aged 30–54 bear half the burden of chronic Hepatitis B and C infections. This demographic insight underscores the urgency of targeted interventions and healthcare strategies to address this public health challenge.
WHO pledges its support to countries in deploying effective tools at accessible prices to combat Hepatitis and reduce its impact on global health. This commitment aims to save lives and reverse the upward trend of Hepatitis infections worldwide.
World AIDS Vaccine Day, also known as HIV Vaccine Awareness Day, is observed annually on…
The Indian government has announced plans for public sector companies like Coal India, NMDC, and…
In April, India's merchandise exports saw a modest 1% increase, reaching $34.99 billion, driven by…
The Open Network for Digital Commerce (ONDC), a digital infrastructure initiative launched in 2021, has…
In response to rising credit demand and falling liquidity, State Bank of India (SBI) has…
The Indian Army is poised to elevate its air defense capabilities with the impending delivery…